Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization

The clinical outcome of patients with a diagnosis of hormone receptor (HR)+ breast cancer has improved remarkably since the arrival of endocrine therapy. Yet, resistance to standard treatments is a major clinical challenge for breast cancer specialists and a life-threatening condition for the patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajjadi, Elham, Venetis, Konstantinos, Piciotti, Roberto, Invernizzi, Marco, Guerini-Rocco , Elena, Haricharan, Svasti, Fusco, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130151/
https://www.ncbi.nlm.nih.gov/pubmed/34001143
http://dx.doi.org/10.1186/s12935-021-01976-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130151/
https://www.ncbi.nlm.nih.gov/pubmed/34001143
http://dx.doi.org/10.1186/s12935-021-01976-y

Ejemplares similares